Novo Nordisk A/S ADR (NVO): Price and Financial Metrics


Novo Nordisk A/S ADR (NVO): $138.09

0.55 (+0.40%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

NVO POWR Grades

  • NVO scores best on the Quality dimension, with a Quality rank ahead of 99.12% of US stocks.
  • NVO's strongest trending metric is Stability; it's been moving up over the last 177 days.
  • NVO ranks lowest in Momentum; there it ranks in the 39th percentile.

NVO Stock Summary

  • NOVO NORDISK A S's market capitalization of $311,060,464,000 is ahead of 99.56% of US-listed equities.
  • With a one year PEG ratio of 797.11, NOVO NORDISK A S is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than 96.54% of US stocks.
  • NVO's went public 37.1 years ago, making it older than 93.53% of listed US stocks we're tracking.
  • If you're looking for stocks that are quantitatively similar to NOVO NORDISK A S, a group of peers worth examining would be ABBV, BABA, LLY, PFE, and MRK.
  • Visit NVO's SEC page to see the company's official filings. To visit the company's web site, go to www.novonordisk.com.

NVO Stock Price Chart Interactive Chart >

Price chart for NVO

NVO Price/Volume Stats

Current price $138.09 52-week high $144.78
Prev. close $137.54 52-week low $94.75
Day low $137.57 Volume 1,105,335
Day high $138.81 Avg. volume 1,496,003
50-day MA $130.33 Dividend yield 0.59%
200-day MA $113.90 Market Cap 312.49B

Novo Nordisk A/S ADR (NVO) Company Bio


Novo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in BagsværdDenmark, with production facilities in nine countries, and affiliates or offices in five countries. Novo Nordisk is controlled by majority shareholder Novo Holdings A/S which holds approximately 25% of its shares and a supermajority (45%) of its voting shares. (Source:Wikipedia)


NVO Latest News Stream


Event/Time News Detail
Loading, please wait...

NVO Latest Social Stream


Loading social stream, please wait...

View Full NVO Social Stream

Latest NVO News From Around the Web

Below are the latest news stories about NOVO NORDISK A S that investors may wish to consider to help them evaluate NVO as an investment opportunity.

These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar

The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.

Yahoo | January 25, 2023

Eli Lilly, Novo Nordisk Get a Share-Price Pop From Weight-Loss Drugs

Eli Lilly rose 33% and Novo Nordisk rose 25% last year behind sales of the first drugs found to cause dramatic weight loss.

Yahoo | January 25, 2023

Novartis' (NVS) Unit to Acquire Astellas' Rights of Mycamine

Novartis' (NVS) generic unit Sandoz is set to acquire rights to the antifungal product Mycamine from Astellas.

Yahoo | January 24, 2023

3 Drug Stocks With Promising Pipelines for 2023

These 3 drug stocks with promising pipelines are in position to reward investors in 2023 due to multiple factors.

Alex Sirois on InvestorPlace | January 23, 2023

Novo Nordisk (NVO) Stock Sinks As Market Gains: What You Should Know

In the latest trading session, Novo Nordisk (NVO) closed at $141.08, marking a -0.01% move from the previous day.

Yahoo | January 23, 2023

Read More 'NVO' Stories Here

NVO Price Returns

1-mo 3.40%
3-mo 26.73%
6-mo 19.43%
1-year 46.23%
3-year 138.15%
5-year 156.11%
YTD 2.03%
2022 22.12%
2021 62.55%
2020 22.56%
2019 27.79%
2018 -12.54%

NVO Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full NVO Dividend History

Continue Researching NVO

Want to see what other sources are saying about Novo Nordisk A S's financials and stock price? Try the links below:

Novo Nordisk A S (NVO) Stock Price | Nasdaq
Novo Nordisk A S (NVO) Stock Quote, History and News - Yahoo Finance
Novo Nordisk A S (NVO) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.7063 seconds.